These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Efficacy and safety of meropenem plus tobramycin followed by meropenem plus vancomycin for treating peritonitis in patients on continuous ambulatory peritoneal dialysis. Kobayashi K, Nakamoto H, Okada S, Hoshitani K, Uchida K, Arima H, Shoda J, Takane Y, Ikeda N, Sugahara S, Okada H, Suzuki H. Adv Perit Dial; 2006; 22():65-8. PubMed ID: 16983942 [Abstract] [Full Text] [Related]
5. Cefepime versus vancomycin plus netilmicin therapy for continuous ambulatory peritoneal dialysis-associated peritonitis. Wong KM, Chan YH, Cheung CY, Chak WL, Choi KS, Leung SH, Leung J, Chau KF, Tsang DN, Li CS. Am J Kidney Dis; 2001 Jul; 38(1):127-31. PubMed ID: 11431192 [Abstract] [Full Text] [Related]
6. Treatment of peritoneal dialysis-associated peritonitis with continuous versus intermittent vancomycin/teicoplanin and ceftazidime in children: preliminary results of a prospective randomized trial. Members of APN Arbeitsgemeinschaft Paidiatrische Nephrologie. Klaus G, Schaefer F, Müller-Wiefel D, Mehls O. Adv Perit Dial; 1995 Jul; 11():296-301. PubMed ID: 8534728 [Abstract] [Full Text] [Related]
8. [The effect of the number of peritonitis episodes on peritoneal membrane function]. Jovanović D, Nesić V, Dimitrijević Z. Srp Arh Celok Lek; 1999 Jul; 127(1-2):28-31. PubMed ID: 10377837 [Abstract] [Full Text] [Related]
9. [Peritonitis in continuous ambulatory peritoneal dialysis. An evaluation of the empiric initial antibiotic treatment]. Hagelskjaer LH, Møller JK. Ugeskr Laeger; 1996 Apr 29; 158(18):2532-7. PubMed ID: 8686006 [Abstract] [Full Text] [Related]
10. Outcome of peritonitis treated with intraperitoneal (i.p.) weekly vancomycin and i.p. daily netilmicin. Chadwick DH, Agarwal S, Vora BJ, Hair M, McKewan A, Gokal R. J Nephrol; 1999 Apr 29; 12(5):318-21. PubMed ID: 10630696 [Abstract] [Full Text] [Related]
14. Peritonitis in continuous ambulatory peritoneal dialysis patients in southern Israel. Benjamin J, Ben-Ezer Gradus D, Mostoslavski M, Rapoport J, Chaimovitz C. Isr J Med Sci; 1989 Dec 29; 25(12):699-702. PubMed ID: 2613500 [Abstract] [Full Text] [Related]
15. Efficacy of vancomycin plus tobramycin as antiperitonitis regimen for patients on CAPD. Vargemezis V, Thodis E, Pasadakis P, Martinis G, Kousta E. Adv Perit Dial; 1990 Dec 29; 6():123-5. PubMed ID: 1982788 [Abstract] [Full Text] [Related]
16. [Our protocol in the treatment of peritonitis in patients on continuous ambulatory peritoneal dialysis]. Kostić S, Ljuvenović S, Velicković R, Stefanović V, Raicević R, Cukuranović R, Veljković S, Djordjević V, Malobabić Z. Srp Arh Celok Lek; 1996 Dec 29; 124 Suppl 1():149-51. PubMed ID: 9102884 [Abstract] [Full Text] [Related]
17. Use of intraperitoneal urokinase for resistant bacterial peritonitis in continuous ambulatory peritoneal dialysis. Tong MK, Leung KT, Siu YP, Lee KF, Lee HK, Yung CY, Kwan TH, Au TC. J Nephrol; 2005 Dec 29; 18(2):204-8. PubMed ID: 15931649 [Abstract] [Full Text] [Related]
18. Pharmacokinetics and bactericidal activity of a single daily dose of netilmicin in the treatment of CAPD-associated peritonitis. Anding K, Krumme B, Pelz K, Böhler J, Schollmeyer P. Int J Clin Pharmacol Ther; 1996 Nov 29; 34(11):465-9. PubMed ID: 8937927 [Abstract] [Full Text] [Related]
19. Treatment and prevention of relapses of CAPD Pseudomonas peritonitis. Pasadakis P, Thodis E, Eftimimiadou A, Panagoutsos S, Papazoglou D, Kaliengidou M, Kartali S, Vargemezis V. Adv Perit Dial; 1993 Nov 29; 9():206-10. PubMed ID: 8105925 [Abstract] [Full Text] [Related]